• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于2021年9月至2022年2月严重急性呼吸综合征冠状病毒2型血清流行率数据的美国感染病例与新冠病毒病例及住院病例的比率

Ratio of Infections to COVID-19 Cases and Hospitalizations in the United States based on SARS-CoV-2 Seroprevalence Data, September 2021-February 2022.

作者信息

Deng Yangyang, Kim Yun, Bratcher Anna, Jones Jefferson M, Simuzingili Muloongo, Gundlapalli Adi V, Hagen Melissa Briggs, Iachan Ronaldo, Clarke Kristie E N

机构信息

ICF Macro, inc., Reston, Virginia, USA.

Epidemic Intelligence Service, CDC, Atlanta, Georgia, USA.

出版信息

Open Forum Infect Dis. 2025 Jan 16;12(1):ofae719. doi: 10.1093/ofid/ofae719. eCollection 2025 Jan.

DOI:10.1093/ofid/ofae719
PMID:39822271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736415/
Abstract

BACKGROUND

Understanding the risk of hospitalization from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can guide effective public health interventions and severity assessments. This study calculated infection-hospitalization ratios (IHRs) and infection-case ratios (ICRs) to understand the relationship between SARS-CoV-2 infections, cases, and hospitalizations among different age groups during periods of Delta and Omicron variant predominance.

METHODS

After calculating antinucleocapsid SARS-CoV-2 antibody seroprevalence using residual commercial laboratory serum specimens, 2 ratios were computed: (1) IHRs using coronavirus disease 2019 hospitalization data and (2) ICRs using Centers for Disease Control and Prevention surveillance data. Ratios were calculated across age groups (0-17, 18-49, 50-69, and ≥70 years) for 2 time periods (September-December 2021 [Delta] and December 2021-February 2022 [Omicron]).

RESULTS

Pediatric IHRs increased from 76.7 during Delta to 258.4 during Omicron. Adult IHRs ranged from 3.0 (≥70 years) to 21.6 (18-49 years) during Delta and from 10.0 (≥70 years) to 119.1 (18-49 years) during Omicron. The pediatric ICR was lower during the Delta period (2.7) compared with the Omicron period (3.7). Adult ICRs (Delta: 1.1 [18-49 years] to 2.1 [70+ years]; Omicron: 2.2 [>70+ years] to 2.9 [50-69 years]) were lower than pediatric ICRs during both time periods.

CONCLUSIONS

All age groups exhibited a lower proportion of infections associated with hospitalization in the Omicron period than the Delta period; the proportion of infections associated with hospitalization increased with each older age group. A lower proportion of SARS-CoV-2 infections were associated with reported cases in the Omicron period than in the Delta period among all age groups.

摘要

背景

了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染导致住院的风险,可为有效的公共卫生干预措施和病情严重程度评估提供指导。本研究计算了感染住院率(IHR)和感染病例率(ICR),以了解在德尔塔和奥密克戎变异株占主导的时期,不同年龄组中SARS-CoV-2感染、病例和住院之间的关系。

方法

在使用商业实验室剩余血清标本计算抗SARS-CoV-2核衣壳抗体血清流行率后,计算了两个比率:(1)使用2019冠状病毒病住院数据计算的IHR,以及(2)使用疾病控制与预防中心监测数据计算的ICR。在两个时间段(2021年9月至12月[德尔塔]和2021年12月至2022年2月[奥密克戎]),按年龄组(0至17岁、18至49岁、50至69岁和≥70岁)计算比率。

结果

儿童IHR从德尔塔时期的76.7增至奥密克戎时期的258.4。成人IHR在德尔塔时期为3.0(≥70岁)至21.6(18至49岁),在奥密克戎时期为10.0(≥70岁)至119.1(18至49岁)。与奥密克戎时期(3.7)相比,德尔塔时期儿童ICR较低(2.7)。在两个时间段,成人ICR(德尔塔:1.1[18至49岁]至2.1[70岁以上];奥密克戎:2.2[70岁以上]至2.9[50至69岁])均低于儿童ICR。

结论

在奥密克戎时期,所有年龄组与住院相关的感染比例均低于德尔塔时期;与住院相关的感染比例随年龄增长而增加。在奥密克戎时期,所有年龄组中与报告病例相关的SARS-CoV-2感染比例均低于德尔塔时期。

相似文献

1
Ratio of Infections to COVID-19 Cases and Hospitalizations in the United States based on SARS-CoV-2 Seroprevalence Data, September 2021-February 2022.基于2021年9月至2022年2月严重急性呼吸综合征冠状病毒2型血清流行率数据的美国感染病例与新冠病毒病例及住院病例的比率
Open Forum Infect Dis. 2025 Jan 16;12(1):ofae719. doi: 10.1093/ofid/ofae719. eCollection 2025 Jan.
2
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
3
Association Between Social Vulnerability and SARS-CoV-2 Seroprevalence in Specimens Collected From Commercial Laboratories, United States, September 2021-February 2022.2021 年 9 月至 2022 年 2 月期间,从美国商业实验室采集的标本中社会脆弱性与 SARS-CoV-2 血清阳性率之间的关联。
Public Health Rep. 2024 Jul-Aug;139(4):501-511. doi: 10.1177/00333549231223140. Epub 2024 Feb 15.
4
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
5
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
6
Pre-Delta, Delta, and Omicron Periods of the Coronavirus Disease 2019 (COVID-19) Pandemic and Health Outcomes During Delivery Hospitalization.2019 年冠状病毒病(COVID-19)大流行的德尔塔前、德尔塔和奥密克戎时期以及分娩住院期间的健康结果。
Obstet Gynecol. 2024 Jan 1;143(1):131-138. doi: 10.1097/AOG.0000000000005449. Epub 2023 Nov 2.
7
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.在加拿大不列颠哥伦比亚省,德尔塔和奥密克戎变异株流行期间,不同年龄组因首次感染 SARS-CoV-2 而住院和死亡的风险。
CMAJ. 2023 Oct 30;195(42):E1427-E1439. doi: 10.1503/cmaj.230721.
8
Autoimmune Sequelae After Delta or Omicron Variant SARS-CoV-2 Infection in a Highly Vaccinated Cohort.高度接种疫苗人群中德尔塔或奥密克戎变异株 SARS-CoV-2 感染后的自身免疫后遗症。
JAMA Netw Open. 2024 Aug 1;7(8):e2430983. doi: 10.1001/jamanetworkopen.2024.30983.
9
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET,14 个州,2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
10
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.

引用本文的文献

1
Mobility-informed metapopulation models predict the spatio-temporal spread of respiratory epidemics across scales.基于移动性的集合种群模型预测了呼吸道流行病在不同尺度上的时空传播。
medRxiv. 2025 Jun 26:2025.06.26.25330297. doi: 10.1101/2025.06.26.25330297.

本文引用的文献

1
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.在加拿大不列颠哥伦比亚省,德尔塔和奥密克戎变异株流行期间,不同年龄组因首次感染 SARS-CoV-2 而住院和死亡的风险。
CMAJ. 2023 Oct 30;195(42):E1427-E1439. doi: 10.1503/cmaj.230721.
2
Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods: September 2020-November 2021.谁会因 COVID-19 生病?2020 年 9 月至 2021 年 11 月阿尔法和德尔塔变异株流行期间严重成人健康结局的社会人口学相关性。
J Infect Dis. 2024 Jan 12;229(1):122-132. doi: 10.1093/infdis/jiad357.
3
COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023.COVID-19 监测在公共卫生紧急事件宣言期满后-美国,2023 年 5 月 11 日。
MMWR Morb Mortal Wkly Rep. 2023 May 12;72(19):523-528. doi: 10.15585/mmwr.mm7219e1.
4
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
5
Epidemiology and Clinical Presentation of COVID-19 in Older Adults.老年人 COVID-19 的流行病学和临床表现。
Infect Dis Clin North Am. 2023 Mar;37(1):1-26. doi: 10.1016/j.idc.2022.11.001. Epub 2022 Nov 4.
6
Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5-17 Years during the Delta and Omicron Periods-United States, December 2020 to April 2022.COVID-19 疫苗接种计划对德尔塔和奥密克戎变异株流行期间 5-17 岁儿童病例发病率、急诊就诊和住院的影响-美国,2020 年 12 月至 2022 年 4 月。
PLoS One. 2022 Dec 9;17(12):e0276409. doi: 10.1371/journal.pone.0276409. eCollection 2022.
7
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022.2020年10月25日至2022年2月26日在美国50个州和哥伦比亚特区进行的一项重复横断面研究中,估计的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体血清流行趋势及其与报告病例流行率的关系。
Lancet Reg Health Am. 2023 Feb;18:100403. doi: 10.1016/j.lana.2022.100403. Epub 2022 Dec 2.
8
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.奥密克戎变异株流行期间抗SARS-CoV-2核衣壳蛋白抗体对突破性感染的敏感性。
J Infect. 2022 Nov;85(5):573-607. doi: 10.1016/j.jinf.2022.08.015. Epub 2022 Aug 20.
9
Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis.奥密克戎变异株引起的 SARS-CoV-2 无症状感染和非重症疾病的比例:系统评价和分析。
J Med Virol. 2022 Dec;94(12):5790-5801. doi: 10.1002/jmv.28066. Epub 2022 Aug 24.
10
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.SARS-CoV-2 核衣壳抗体的纵向动力学、血清学转换及其对血清流行病学研究的意义。
Emerg Infect Dis. 2022 Sep;28(9):1859-1862. doi: 10.3201/eid2809.220729. Epub 2022 Jul 22.